BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[Bristol-Myers Squibb (BMY) rides Plavix sales to higher earnings]]>http://www.bloggingstocks.com/2007/10/25/bristol-myers-squibb-bmy-rides-plavix-sales-to-higher-earnings/http://www.bloggingstocks.com/2007/10/25/bristol-myers-squibb-bmy-rides-plavix-sales-to-higher-earnings/http://www.bloggingstocks.com/2007/10/25/bristol-myers-squibb-bmy-rides-plavix-sales-to-higher-earnings/#commentsFiled under: , ,

Bristol-Myers Squibb (NYSE: BMY) announced today that third-quarter earnings were solidly higher, resulting in an increased target for overall 2007 earnings. In the latest reporting period, the drug manufacturer posted net income of $858 million, or 43 cents per share, up from a year-ago profit of $338 million (17 cents per share). Excluding items, the company banked 38 cents per share, or a penny better than Wall Street's expectations.

Revenue was higher during the period as well, up 22% to $5.05 billion, edging out analysts' consensus view of $5.02 billion.

Helping the company achieve these robust profits was BMY's blood-thinning medication Plavix, which saw sales double to $1.25 billion. The company is continuing a legal battle with Apotex over a generic version of Plavix, which hit shelves last August but has been pulled amid a patent dispute. The Plavix patent is scheduled to expire in 2011. Generic competition had negative repercussions for cholesterol drug Pravachol, which saw sales drop 55% in the third quarter as a result.

Continue reading Bristol-Myers Squibb (BMY) rides Plavix sales to higher earnings

Bristol-Myers Squibb (BMY) rides Plavix sales to higher earnings originally appeared on BloggingStocks on Thu, 25 Oct 2007 12:44:00 EST. Please see our terms for use of feeds.

Read | Permalink | Email this | Comments]]>ApotexBMYearningsinthenewsPlavixPravacholrevenueThu, 25 Oct 2007 12:44:00 EST